U.S. market Closed. Opens in 4 hours 34 minutes

NPCE | NeuroPace, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 12.25 - 13.77
52 Week Range 5.45 - 18.15
Beta 1.10
Implied Volatility 128.04%
IV Rank 13.25%
Day's Volume 256,912
Average Volume 91,846
Shares Outstanding 29,848,100
Market Cap 389,816,186
Sector Healthcare
Industry Medical - Devices
IPO Date 2021-04-22
Valuation
Profitability
Growth
Health
P/E Ratio -13.33
Forward P/E Ratio N/A
EPS -0.98
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 184
Country USA
Website NPCE
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
*Chart delayed
Analyzing fundamentals for NPCE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see NPCE Fundamentals page.

Watching at NPCE technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on NPCE Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙